Infection with the mpox virus (MPXV) confers strong immunity against future infection for up to two years, compared with vaccine-conferred protection, which wanes with time and requires boosting, researchers in Belgium and the Netherlands
Mpox infection triggers stronger, longer-term protection than vaccination, study suggests
